Skip to content
TwitterLinkedinInstagram
info@pharmaust.com+61 8 6161 7412
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • Management Team
    • Board
    • Advisory Committee
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL and Veterinary Trials
    • MPL and Human Trials
    • Publications
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • Management Team
    • Board
    • Advisory Committee
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL and Veterinary Trials
    • MPL and Human Trials
    • Publications
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Investor Presentations

  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

Appendix 4D and Financial Report

Financial Reports 2019, News & Announcements 2019By Richard MollardMarch 1, 2019

190301_Appendix 4D and Financial Report

Read more

Section 708A

Financial Reports 2019, News & Announcements 2019By Richard MollardFebruary 18, 2019

190218_Section 708A

Read more

Appendix 3B

Financial Reports 2019, News & Announcements 2019By Richard MollardFebruary 18, 2019

190218_Appendix 3B

Read more

Appendix 3B Amendment

Financial Reports 2019, News & Announcements 2019By Richard MollardFebruary 14, 2019

190214_Appendix 3B Amendment

Read more

Section 708A

Financial Reports 2019, News & Announcements 2019By Richard MollardFebruary 7, 2019

190207_Section 708A

Read more

Appendix 3B

Financial Reports 2019, News & Announcements 2019By Richard MollardFebruary 7, 2019

190207_Appendix 3B

Read more

December 2018 Appendix 4C Quarterly Report and Company Update

Financial Reports 2019, News & Announcements 2019By Richard MollardJanuary 31, 2019

190131_4C

Read more

Investor Presentation (August)

August 31, 2017

Investor Presentation (May)

May 10, 2017

PharmAust AGM presentation

November 10, 2016

PharmAust Investor Presentation – June 2016

August 10, 2016

USA Roadshow Presentation – January 2016

January 15, 2016

PharmAust AGM Presentation 2015

October 27, 2015

EGM Shareholder Presentation

May 26, 2015

PharmAust Shareholder Presentation – March 2015

March 15, 2015
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAustFollow

PharmAust
PharmAustPharmAust@PharmAust·
14 Mar

PharmAust is basking in the early success of Phase I clinical trials for its flagship anti-cancer drug Monepantel in dogs. https://t.co/Mv2qtDMfjE

Reply on TwitterRetweet on Twitter1Like on Twitter1Twitter
Load More...
Copyright © 2019 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top